Non Invasive Blood Pressure

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Element Biosciences
Element BiosciencesCA - San Diego
2 programs
Non Invasive Blood PressureN/A1 trial
Non-invasive blood pressureN/A1 trial
Active Trials
NCT06980766CompletedEst. Mar 2025
NCT06682312TerminatedEst. Oct 2024

Trial Timeline

Clinical trial activity over time

2024
2025
2026
Element BiosciencesNon Invasive Blood Pressure
Element BiosciencesNon-invasive blood pressure

Clinical Trials (2)

NCT06980766Element BiosciencesNon Invasive Blood Pressure

Philips Non-Invasive Blood Pressure Validation Study of VS30 Monitor

Start: Mar 2025Est. completion: Mar 2025
N/ACompleted
NCT06682312Element BiosciencesNon-invasive blood pressure

Philips Non-Invasive Blood Pressure Validation Study

Start: Oct 2024Est. completion: Oct 2024
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space